Paul Mahon
2020
In 2020, Paul Mahon earned a total compensation of $4.1M as Executive Vice Presidentand General Counsel at United Therapeutics, a 75% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $2,432,869 |
|---|---|
| Non-Equity Incentive Plan | $737,880 |
| Salary | $908,077 |
| Other | $22,400 |
| Total | $4,101,226 |
Mahon received $2.4M of change in pension value and nonqualified deferred compensation earnings, accounting for 59% of the total pay in 2020.
Mahon also received $737.9K in non-equity incentive plan, $908.1K in salary and $22.4K in other compensation.
Rankings
In 2020, Paul Mahon's compensation ranked 2,771st out of 13,090 executives tracked by ExecPay. In other words, Mahon earned more than 78.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,771 out of 13,090 | 79th |
Division Manufacturing | 1,060 out of 5,621 | 81st |
Major group Chemicals And Allied Products | 394 out of 2,254 | 83rd |
Industry group Drugs | 340 out of 1,954 | 83rd |
Industry Pharmaceutical Preparations | 247 out of 1,459 | 83rd |
Source: SEC filing on April 29, 2022.
Mahon's colleagues
We found three more compensation records of executives who worked with Paul Mahon at United Therapeutics in 2020.